We are live on ! Find out more
PRVB

Provention Bio, Inc. Common Stock
PRVB

Delisted

PRVB was delisted on the 26th of April, 2023.

Back to rankings

60 hedge funds and large institutions have $131M invested in Provention Bio, Inc. Common Stock in 2019 Q4 according to their latest regulatory filings, with 24 funds opening new positions, 19 increasing their positions, 12 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

211% more capital invested

Capital invested by funds: $42.2M → $131M (+$88.9M)

118% more first-time investments, than exits

New positions opened: 24 | Existing positions closed: 11

109% more call options, than puts

Call options by funds: $3.75M | Put options by funds: $1.79M

58% more repeat investments, than reductions

Existing positions increased: 19 | Existing positions reduced: 12

25% more funds holding

Funds holding: 48 → 60 (+12)

Holders
60
Holders Change
+12
Holders Change %
+25%
% of All Funds
1.18%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
24
Increased
19
Reduced
12
Closed
11
Calls
$3.75M
Puts
$1.79M
Net Calls
+$1.96M
Net Calls Change
+$2.24M

Top Buyers

Rank Fund Capital Flow
1
PA
Perceptive Advisors
New York
+$20.1M
2
BlackRock
BlackRock
New York
+$1.55M
3
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$1.41M
4
Invesco
Invesco
Georgia
+$1.36M
5
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT)
United Kingdom
+$1.33M

Top Sellers

Rank Fund Capital Flow
1
DM
Deerfield Management
New York
-$4.95M
2
SCM
Segantii Capital Management
Hong Kong
-$4.13M
3
Morgan Stanley
Morgan Stanley
New York
-$1.76M
4
MS
Maven Securities
Jersey
-$1.7M
5
MWNA
Marshall Wace North America
New York
-$1.37M
Name Holding Trade Value Shares
Change 		Change in
Stake
PA
1
Perceptive Advisors
New York
$43.5M +$20.1M +2,255,252 +338%
Vanguard Group
2
Vanguard Group
Pennsylvania
$20.3M +$257K +28,816 +2%
JJIJ
3
Johnson & Johnson Innovation - JJDC
New Jersey
$16.8M +$10M +1,124,973 New
BlackRock
4
BlackRock
New York
$9.79M +$1.55M +173,917 +36%
SCM
5
Segantii Capital Management
Hong Kong
$3.89M -$4.13M -463,400 -64%
Geode Capital Management
6
Geode Capital Management
Massachusetts
$3.79M -$107K -11,986 -5%
Susquehanna International Group
7
Susquehanna International Group
Pennsylvania
$2.98M +$1.41M +158,266 +376%
Invesco
8
Invesco
Georgia
$2.28M +$1.36M +152,962 New
Qube Research & Technologies (QRT)
9
Qube Research & Technologies (QRT)
United Kingdom
$2.23M +$1.33M +149,392 New
CS
10
Credit Suisse
Switzerland
$1.84M +$1.1M +123,768 New
ECM
11
ExodusPoint Capital Management
New York
$1.79M +$874K +98,131 +440%
Verition Fund Management
12
Verition Fund Management
Connecticut
$1.72M -$1.18M -132,720 -53%
BAAM
13
Baker Avenue Asset Management
California
$1.36M +$813K +91,250 New
SPC
14
Sigma Planning Corp
Michigan
$1.2M +$102K +11,485 +17%
Macquarie Group
15
Macquarie Group
Australia
$1.04M – – –
WAM
16
Wealthspire Advisors (Maryland)
Maryland
$1.04M +$66.8K +7,500 +12%
LCM
17
Laurion Capital Management
New York
$1.02M +$490K +54,940 +410%
Northern Trust
18
Northern Trust
Illinois
$1M +$150K +16,870 +34%
RHJA
19
Rice Hall James & Associates
California
$873K +$522K +58,568 New
Stifel Financial
20
Stifel Financial
Missouri
$823K -$176K -19,800 -26%
Wells Fargo
21
Wells Fargo
California
$788K +$329K +36,957 +231%
Truist Financial
22
Truist Financial
North Carolina
$775K +$463K +52,000 New
B
23
Bailard
California
$749K -$44.6K -5,000 -9%
Bank of New York Mellon
24
Bank of New York Mellon
New York
$708K +$316K +35,428 +293%
California Public Employees Retirement System
25
California Public Employees Retirement System
California
$679K +$406K +45,574 New
1
2 3

PRVB Hedge Fund Activity: Q4 2019 in Review

60 of the 5,075 institutional investors tracked by Wall St. Rank reported a position in Provention Bio, Inc. Common Stock (PRVB) for Q4 2019, worth a combined $131M — up 211% from $42.2M a quarter earlier.

Buyers outnumbered sellers: 24 funds opened new PRVB positions and 11 closed out — a net gain of 13 holders — while 19 added to existing stakes and 12 trimmed.

The largest buyer was Perceptive Advisors, adding an estimated $20.1M. The largest seller was Deerfield Management, exiting entirely with an estimated $4.95M sold.

  • 60 institutional investors held Provention Bio, Inc. Common Stock (PRVB) as of Q4 2019, up from 48 in Q3 2019.
  • Funds reported $131M of Provention Bio, Inc. Common Stock stock for Q4 2019, up 211% quarter-over-quarter.
  • 24 funds opened new Provention Bio, Inc. Common Stock positions in Q4 2019 and 11 closed out, a net change of +13 holders.
  • The largest Provention Bio, Inc. Common Stock buyer in Q4 2019 was Perceptive Advisors, an estimated $20.1M added.
  • The largest Provention Bio, Inc. Common Stock seller in Q4 2019 was Deerfield Management, an estimated $4.95M sold.

Based on aggregated 13F filings for Q4 2019.